Association of EFS and DRFS With pCR in Neoadjuvant Treatment of Stage 2 and 3 Breast Cancer

This randomized clinical trial evaluates the association of pathologic complete response with event-free survival and distant recurrence–free survival in subpopulations of women with high-risk operable breast cancer treated with standard therapy or one of several novel agents.